Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1985 May;60:35–39. doi: 10.1289/ehp.856035

Effects of PCBs and related compounds on hepatocarcinogenesis in rats and mice.

S Sleight
PMCID: PMC1568543  PMID: 2992924

Abstract

Commercial mixtures of polychlorinated biphenyls (PCBs) and polybrominated biphenyls (PBBs) can cause hepatocellular carcinoma in rats and mice. Present evidence indicates that these chemicals act as promoters and not initiators of hepatocarcinogenesis. Our results show that Firemaster BP-6 (FM) and its nontoxic major congener, 2,2', 4,4', 5,5'-hexabromobiphenyl (HBB), act as promoters in the two-stage model for hepatocarcinogenesis devised by Pitot and associates. A toxic congener, 3,3', 4,4', 5,5'-HBB, also was assessed for tumor-promoting activity. This congener, though not in FM, is similar to TCDD, in that both cause 3-methylcholanthrene (MC)-type induction of hepatic microsomal enzymes and produce similar toxic responses. FM contains several congeners which are mixed-type inducers in that they induce MC-type and phenobarbital (PB)-type enzymes. The toxicity of FM is most likely associated with its congeners which are mixed-type inducers and not to relatively nontoxic congeners such as 2,2', 4,4', 5,5'-HBB which are strictly PB-type inducers. Congener 3,3', 4,4', 5,5'-HBB acted as a tumor promoter only at a dose that was hepatotoxic. A synergistic effect on tumor promoting ability was produced by combining a nontoxic and nonpromoting dose of 3,3', 4,4', 5,5'-HBB with a promoting dose of 2,2', 4,4', 5,5'-HBB. Our results suggest that synergism between toxic and nontoxic congeners in FM may explain why mixtures such as FM have greater promoting ability than individual congeners. Our results also indicate that with PBB, toxicity and carcinogenicity are not necessarily related.

Full text

PDF
35

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berry D. L., Slaga T. J., DiGiovanni J., Juchau M. R. Studies with chlorinated dibenzo-p-dioxins, polybrominated biphenyls, and polychlorinated biphenyls in a two-stage system of mouse skin tumorigenesis: potent anticarcinogenic effects. Ann N Y Acad Sci. 1979 May 31;320:405–414. doi: 10.1111/j.1749-6632.1979.tb56621.x. [DOI] [PubMed] [Google Scholar]
  2. Dannan G. A., Moore R. W., Aust S. D. Studies on the microsomal metabolism and binding of polybrominated biphenyls (PBBs). Environ Health Perspect. 1978 Apr;23:51–61. doi: 10.1289/ehp.782351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dannan G. A., Sleight S. D., Aust S. D. Toxicity and microsomal enzyme induction effects of several polybrominated biphenyls of Firemaster. Fundam Appl Toxicol. 1982 Nov-Dec;2(6):313–321. doi: 10.1016/s0272-0590(82)80011-0. [DOI] [PubMed] [Google Scholar]
  4. Dannan G. A., Sleight S. D., Fraker P. J., Krehbiel J. D., Aust S. D. Liver microsomal enzyme induction and toxicity studies with 2,4,5,3',4'-pentabromobiphenyl. Toxicol Appl Pharmacol. 1982 Jun 30;64(2):187–203. doi: 10.1016/0041-008x(82)90215-0. [DOI] [PubMed] [Google Scholar]
  5. Deml E., Oesterle D. Sex-dependent promoting effect of polychlorinated biphenyls on enzyme-altered islands induced by diethylnitrosamine in rat liver. Carcinogenesis. 1982;3(12):1449–1452. doi: 10.1093/carcin/3.12.1449. [DOI] [PubMed] [Google Scholar]
  6. Farber E. Chemical carcinogenesis: a biologic perspective. Am J Pathol. 1982 Feb;106(2):271–296. [PMC free article] [PubMed] [Google Scholar]
  7. Farber E. The sequential analysis of liver cancer induction. Biochim Biophys Acta. 1980 May 6;605(2):149–166. doi: 10.1016/0304-419x(80)90002-5. [DOI] [PubMed] [Google Scholar]
  8. Garthoff L. H., Friedman L., Farber T. M., Locke K. K., Sobotka T. J., Green S., Hurley N. E., Peters E. L., Story G. E., Moreland F. M. Biochemical and cytogenetic effects in rats caused by short-term ingestion of Aroclor 1254 or Firemaster BP6. J Toxicol Environ Health. 1977 Nov;3(4):769–796. doi: 10.1080/15287397709529612. [DOI] [PubMed] [Google Scholar]
  9. Gupta B. N., McConnell E. E., Moore J. A., Haseman J. K. Effects of a polybrominated biphenyl mixture in the rat and mouse. II. Lifetime study. Toxicol Appl Pharmacol. 1983 Mar 30;68(1):19–35. doi: 10.1016/0041-008x(83)90351-4. [DOI] [PubMed] [Google Scholar]
  10. Ito N., Nagasaki H., Arai M., Makiura S., Sugihara S., Hirao K. Histopathologic studies on liver tumorigenesis induced in mice by technical polychlorinated biphenyls and its promoting effect on liver tumors induced by benzene hexachloride. J Natl Cancer Inst. 1973 Nov;51(5):1637–1646. doi: 10.1093/jnci/51.5.1637. [DOI] [PubMed] [Google Scholar]
  11. Ito N., Nagasaki H., Makiura S., Arai M. Histopathological studies on liver tumorigenesis in rats treated with polychlorinated biphenyls. Gan. 1974 Dec;65(6):545–549. [PubMed] [Google Scholar]
  12. Jensen R. K., Sleight S. D., Aust S. D., Goodman J. I., Trosko J. E. Hepatic tumor-promoting ability of 3,3',4,4',5,5'-hexabromobiphenyl: the interrelationship between toxicity, induction of hepatic microsomal drug metabolizing enzymes, and tumor-promoting ability. Toxicol Appl Pharmacol. 1983 Nov;71(2):163–176. doi: 10.1016/0041-008x(83)90333-2. [DOI] [PubMed] [Google Scholar]
  13. Jensen R. K., Sleight S. D., Goodman J. I., Aust S. D., Trosko J. E. Polybrominated biphenyls as promoters in experimental hepatocarcinogenesis in rats. Carcinogenesis. 1982;3(10):1183–1186. doi: 10.1093/carcin/3.10.1183. [DOI] [PubMed] [Google Scholar]
  14. Kay K. Polybrominated biphenyls (PBB) environmental contamination in Michigan, 1973-1976. Environ Res. 1977 Feb;13(1):74–93. doi: 10.1016/0013-9351(77)90006-8. [DOI] [PubMed] [Google Scholar]
  15. Kimbrough R. D., Groce D. F., Korver M. P., Burse V. W. Induction of liver tumors in female Sherman strain rats by polybrominated biphenyls. J Natl Cancer Inst. 1981 Mar;66(3):535–542. [PubMed] [Google Scholar]
  16. Kimbrough R. D., Linder R. E., Gaines T. B. Morphological changes in livers of rats fed polychlorinated biphenyls: light microscopy and ultrastructure. Arch Environ Health. 1972 Nov;25(5):354–364. doi: 10.1080/00039896.1972.10666186. [DOI] [PubMed] [Google Scholar]
  17. Kimbrough R. D., Linder R. E. Induction of adenofibrosis and hepatomas of the liver in BALB-cJ mice by polychlorinated biphenyls (Aroclor 1254). J Natl Cancer Inst. 1974 Aug;53(2):547–552. doi: 10.1093/jnci/53.2.547. [DOI] [PubMed] [Google Scholar]
  18. Kimbrough R. D., Squire R. A., Linder R. E., Strandberg J. D., Montalli R. J., Burse V. W. Induction of liver tumor in Sherman strain female rats by polychlorinated biphenyl aroclor 1260. J Natl Cancer Inst. 1975 Dec;55(6):1453–1459. doi: 10.1093/jnci/55.6.1453. [DOI] [PubMed] [Google Scholar]
  19. Kimbrough R. D. The carcinogenic and other chronic effects of persistent halogenated organic compounds. Ann N Y Acad Sci. 1979 May 31;320:415–418. doi: 10.1111/j.1749-6632.1979.tb56622.x. [DOI] [PubMed] [Google Scholar]
  20. Kimura N. T., Baba T. Neoplastic changes in the rat liver induced by polychlorinated biphenyl. Gan. 1973 Feb;64(1):105–108. [PubMed] [Google Scholar]
  21. Kimura N. T., Kanematsu T., Baba T. Polychlorinated biphenyl(s) as a promotor in experimental hepatocarcinogenesis in rats. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1976 Dec 9;87(3):257–266. doi: 10.1007/BF00506498. [DOI] [PubMed] [Google Scholar]
  22. Kociba R. J., Keyes D. G., Beyer J. E., Carreon R. M., Wade C. E., Dittenber D. A., Kalnins R. P., Frauson L. E., Park C. N., Barnard S. D. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol Appl Pharmacol. 1978 Nov;46(2):279–303. doi: 10.1016/0041-008x(78)90075-3. [DOI] [PubMed] [Google Scholar]
  23. Laishes B. A., Roberts E., Farber E. In vitro measurement of carcinogen-resistant liver cells during hepatocarcinogenesis. Int J Cancer. 1978 Feb 15;21(2):186–193. doi: 10.1002/ijc.2910210210. [DOI] [PubMed] [Google Scholar]
  24. Makiura S., Aoe H., Sugihara S., Hirao K., Arai M. Inhibitory effect of polychlorinated biphenyls on liver tumorigenesis in rats treated with 3'-methyl-4-dimethylaminoazobenzene, n-2-fluorenylacetamide, and diethylnitrosamine. J Natl Cancer Inst. 1974 Nov;53(5):1253–1257. doi: 10.1093/jnci/53.5.1253. [DOI] [PubMed] [Google Scholar]
  25. Moore R. W., Sleight S. D., Aust S. D. Induction of liver microsomal drug-metabolizing enzymes by 2,2',4,4',5,5'-hexabromobiphenyl. Toxicol Appl Pharmacol. 1978 May;44(2):309–321. doi: 10.1016/0041-008x(78)90193-x. [DOI] [PubMed] [Google Scholar]
  26. Oesterle D., Deml E. Promoting effect of polychlorinated biphenyls on development of enzyme-altered islands in livers of weanling and adult rats. J Cancer Res Clin Oncol. 1983;105(2):141–147. doi: 10.1007/BF00406924. [DOI] [PubMed] [Google Scholar]
  27. Peraino C., Fry R. J., Staffeldt E., Kisieleski W. E. Effects of varying the exposure to phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat. Cancer Res. 1973 Nov;33(11):2701–2705. [PubMed] [Google Scholar]
  28. Pereira M. A., Herren S. L., Britt A. L., Khoury M. M. Promotion by polychlorinated biphenyls of enzyme-altered foci in rat liver. Cancer Lett. 1982 Feb;15(2):185–190. doi: 10.1016/0304-3835(82)90050-7. [DOI] [PubMed] [Google Scholar]
  29. Pitot H. C., Barsness L., Goldsworthy T., Kitagawa T. Biochemical characterisation of stages of hepatocarcinogenesis after a single dose of diethylnitrosamine. Nature. 1978 Feb 2;271(5644):456–458. doi: 10.1038/271456a0. [DOI] [PubMed] [Google Scholar]
  30. Pitot H. C., Goldsworthy T., Moran S., Sirica A. E., Weeks J. Properties of incomplete carcinogens and promoters in hepatocarcinogenesis. Carcinog Compr Surv. 1982;7:85–98. [PubMed] [Google Scholar]
  31. Preston B. D., Van Miller J. P., Moore R. W., Allen J. R. Promoting effects of polychlorinated biphenyls (Aroclor 1254) and polychlorinated dibenzofuran-free Aroclor 1254 on diethylnitrosamine-induced tumorigenesis in the rat. J Natl Cancer Inst. 1981 Mar;66(3):509–515. [PubMed] [Google Scholar]
  32. Pugh T. D., Goldfarb S. Quantitative histochemical and autoradiographic studies of hepatocarcinogenesis in rats fed 2-acetylaminofluorene followed by phenobarbital. Cancer Res. 1978 Dec;38(12):4450–4457. [PubMed] [Google Scholar]
  33. Render J. A., Aust S. D., Sleight S. D. Acute pathologic effects of 3,3',4,4',5,5'-hexabromobiphenyl in rats: comparison of its effects with Firemaster BP-6 and 2,2',4,4',5,5'-hexabromobiphenyl. Toxicol Appl Pharmacol. 1982 Mar 15;62(3):428–444. doi: 10.1016/0041-008x(82)90144-2. [DOI] [PubMed] [Google Scholar]
  34. Scherer E., Emmelot P. Kinetics of induction and growth of precancerous liver-cell foci, and liver tumour formation by diethylnitrosamine in the rat. Eur J Cancer. 1975 Oct;11(10):689–696. doi: 10.1016/0014-2964(75)90042-0. [DOI] [PubMed] [Google Scholar]
  35. Schulte-Hermann R., Ohde G., Schuppler J., Timmermann-Trosiener I. Enhanced proliferation of putative preneoplastic cells in rat liver following treatment with the tumor promoters phenobarbital, hexachlorocyclohexane, steroid compounds, and nafenopin. Cancer Res. 1981 Jun;41(6):2556–2562. [PubMed] [Google Scholar]
  36. Schulte-Hermann R., Parzefall W. Failure to discriminate initiation from promotion of liver tumors in a long-term study with the phenobarbital-type inducer alpha-hexachlorocyclohexane and the role of sustained stimulation of hepatic growth and monooxygenases. Cancer Res. 1981 Oct;41(10):4140–4146. [PubMed] [Google Scholar]
  37. Schulte-Hermann R., Timmermann-Trosiener I., Schuppler J. Promotion of spontaneous preneoplastic cells in rat liver as a possible explanation of tumor production by nonmutagenic compounds. Cancer Res. 1983 Feb;43(2):839–844. [PubMed] [Google Scholar]
  38. Sleight S. D., Sanger V. L. Pathologic features of polybrominated biphenyl toxicosis in the rat and guinea pig. J Am Vet Med Assoc. 1976 Dec 1;169(11):1231–1235. [PubMed] [Google Scholar]
  39. Squire R. A., Levitt M. H. Report of a workshop on classification of specific hepatocellular lesions in rats. Cancer Res. 1975 Nov;35(11 Pt 1):3214–3223. [PubMed] [Google Scholar]
  40. Trosko J. E., Yotti L. P., Warren S. T., Tsushimoto G., Chang C. Inhibition of cell-cell communication by tumor promoters. Carcinog Compr Surv. 1982;7:565–585. [PubMed] [Google Scholar]
  41. Tsushimoto G., Trosko J. E., Chang C. C., Aust S. D. Inhibition of metabolic cooperation in Chinese hamster V79 cells in culture by various polybrominated biphenyl (PBB) congeners. Carcinogenesis. 1982;3(2):181–185. doi: 10.1093/carcin/3.2.181. [DOI] [PubMed] [Google Scholar]
  42. Williams G. M., Katayama S., Ohmori T. Enhancement of hepatocarcinogenesis by sequential administration of chemicals: summation versus promotion effects. Carcinogenesis. 1981;2(11):1111–1117. doi: 10.1093/carcin/2.11.1111. [DOI] [PubMed] [Google Scholar]
  43. Williams G. M., Klaiber M., Parker S. E., Farber E. Nature of early appearing, carcinogen-induced liver lesions to iron accumulation. J Natl Cancer Inst. 1976 Jul;57(1):157–165. doi: 10.1093/jnci/57.1.157. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES